Beacon Investment Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Beacon Investment Advisors's AMGN Position: Q1 2026 in Review
Beacon Investment Advisors reduced its Amgen (AMGN) stake by 0.05% in Q1 2026, selling an estimated $356 and leaving 1,847 shares worth $650K. The position accounts for 0.25% of the portfolio, ranked #91.
Beacon Investment Advisors first reported a position in AMGN in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.69M in Q4 2023. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Beacon Investment Advisors held 1,847 shares of Amgen worth $650K as of Q1 2026.
- Beacon Investment Advisors sold 1 Amgen share in Q1 2026, an estimated $356.
- Amgen made up 0.25% of Beacon Investment Advisors's portfolio in Q1 2026, its #91 holding.
- Beacon Investment Advisors first reported a position in Amgen in Q4 2022 and has held it in 14 quarters since.
- Beacon Investment Advisors's Amgen position peaked at $2.69M in Q4 2023.
- 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Beacon Investment Advisors's 13F filing for Q1 2026, filed 14 May 2026.